Pure Global

QIAstat-Dx Respiratory SARS-CoV-2 Panel - Indonesia BPOM Medical Device Registration

QIAstat-Dx Respiratory SARS-CoV-2 Panel is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303321261. The device is manufactured by QIAGEN GMBH. from Germany, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. UBC MEDICAL INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
QIAstat-Dx Respiratory SARS-CoV-2 Panel
Analysis ID: AKL 20303321261

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

QIAGEN GMBH.

Country of Origin

Germany

Authorized Representative

PT. UBC MEDICAL INDONESIA

AR Address

Jalan Rawa Gelam V, Blok L Kav. 11-13, Kawasan Industri Pulogadung Jakarta Timur13930

Registration Date

Jul 14, 2023

Expiry Date

Nov 08, 2027

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name